A Study to Assess the Cholesterol Lowering Effect of Ezetimibe/Simvastatin Combination Tablet Compared to Another Cholesterol Lowering Drug in Elderly Patients With High Cholesterol at High or Moderately High Risk for Coronary Heart Disease (0653A-128)

NCT00535405 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1289

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolemia

Interventions

DRUG: Atorvastatin 10 mg
DRUG: Ezetimibe 10 mg/simvastatin 20 mg
DRUG: Atorvastatin 20 mg
DRUG: Ezetimibe 10 mg/simvastatin 40 mg
DRUG: Atorvastatin 40 mg

Sponsor

Organon and Co

Collaborators

[object Object]